Lexology March 13, 2020
Krieg DeVault

With the spread of the coronavirus (COVID-19), and tri-fold spread of fear relating to the same, State agencies have begun to take action with respect to care relating to coronavirus. Specifically, State Medicaid programs across the nation are beginning to review both cost-sharing policies, such as member co-payments, as well as utilization review policies, such as prior authorization processes, to ensure timely access to care for Medicaid beneficiaries. In some states, there are similar actions being taken with commercial insurance through State Insurance departments.

The Indiana Family and Social Services Administration (FSSA) recently announced that Indiana Medicaid will cover all COVID-19 diagnostic testing without copayments from members. In addition, two new codes specific to the diagnostic panel and laboratory tests...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Healthcare System, Insurance, Medicaid, Patient / Consumer, Provider, Trends
What the Medicaid unwinding means for plans, providers, and more
New Federal Rules for Medicaid Advisory Committees and Beneficiary Advisory Councils
CMS Publishes Final Rule on Programs of All-Inclusive Care for the Elderly (PACE)
CMS final rules to boost Medicaid, CHIP access and payment: 11 things to know
New federal rule establishes minimum staffing levels for nursing homes

Share This Article